Candriam S.C.A. Codexis, Inc. Transaction History

Candriam S.C.A.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$3.81 - $6.76 $193,982 - $344,178	-50,914 Reduced 32.03%	108,061 $447,000
Q4 2022 Feb 13, 2023	BUY	$4.26 - $6.84 $68,253 - $109,590	16,022 Added 11.21%	158,975 $740,000
Q3 2022 Nov 10, 2022	BUY	$6.06 - $12.86 $866,295 - $1.84 Million	142,953 New	142,953 $866,000
Q2 2020 Jul 23, 2020	SELL	$9.8 - $12.77 $880,569 - $1.15 Million	-89,854 Closed	0 $0
Q1 2020 May 26, 2020	BUY	$8.78 - $18.6 $711 - $1,506	81 Added 0.09%	89,854 $1.4 Million
Q4 2019 Jan 21, 2020	BUY	$13.12 - $17.06 $817,756 - $1.06 Million	62,329 Added 227.11%	89,773 $1,000
Q2 2019 Aug 01, 2019	BUY	$17.0 - $21.88 $466,548 - $600,474	27,444 New	27,444 $504,000

125

59.9M

25.9K

20.1K

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $335M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.